Literature DB >> 26264260

Activity of several kinds of drugs against Neospora caninum.

Weifeng Qian1, Hui Wang2, Dan Shan2, Bo Li2, Jing Liu2, Qun Liu3.   

Abstract

Neosporosis caused by Neospora caninum is a serious disease in cattle and dogs worldwide. It is the major cause of abortion and neonatal mortality in cattle. In this study, we evaluated the anti-N. caninum activity of Chinese medicine extracts (curcumin, artemether), herbicides (atrazine, glyphosate), anticoccidiosis drugs (toltrazuril and ponazuril), cyclophosphamide, diminazene aceturate and praziquantel in vitro using parasite growth, replication and host cell invasion assays in human foreskin fibroblast cultures. Curcumin, artemether, atrazine, toltrazuril and ponazuril exhibited inhibitory activity with 50% growth inhibitory concentration (IC50) of 1.1±0.4, 1.0±0.05, 11.2±2.7, 30.3±2.0 and 33.3±4.1μg/ml, respectively, in the growth inhibition assay. They were also active against protozoa replication, but only curcumin was effective against host cell invasion. Glyphosate, cyclophosphamide, diminazene aceturate and praziquantel were ineffective. In an in vivo infection model, curcumin showed no activity against N. caninum infection. We showed that curcumin, artemether, atrazine, toltrazuril, and ponazuril exhibited anti-N. caninum activity in vitro, providing important information for further studies on anti-N. caninum drugs.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Drugs; Effective; Mice; Neospora caninum; Toxicity

Mesh:

Substances:

Year:  2015        PMID: 26264260     DOI: 10.1016/j.parint.2015.08.002

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  7 in total

Review 1.  Artemisinin and its derivatives in treating protozoan infections beyond malaria.

Authors:  Cecilia Shi Ni Loo; Nelson Siu Kei Lam; Deying Yu; Xin-Zhuan Su; Fangli Lu
Journal:  Pharmacol Res       Date:  2016-11-17       Impact factor: 7.658

2.  Enrofloxacin and Toltrazuril Are Able to Reduce Toxoplasma gondii Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy.

Authors:  Rafaela J da Silva; Angelica O Gomes; Priscila S Franco; Ariane S Pereira; Iliana C B Milian; Mayara Ribeiro; Paolo Fiorenzani; Maria C Dos Santos; José R Mineo; Neide M da Silva; Eloisa A V Ferro; Bellisa de Freitas Barbosa
Journal:  Front Cell Infect Microbiol       Date:  2017-07-26       Impact factor: 5.293

3.  Inhibitory action of phenothiazinium dyes against Neospora caninum.

Authors:  Luiz Miguel Pereira; Caroline Martins Mota; Luciana Baroni; Cássia Mariana Bronzon da Costa; Jade Cabestre Venancio Brochi; Mark Wainwright; Tiago Wilson Patriarca Mineo; Gilberto Úbida Leite Braga; Ana Patrícia Yatsuda
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

Review 4.  Curcumin: Biological Activities and Modern Pharmaceutical Forms.

Authors:  Maja Urošević; Ljubiša Nikolić; Ivana Gajić; Vesna Nikolić; Ana Dinić; Vojkan Miljković
Journal:  Antibiotics (Basel)       Date:  2022-01-20

5.  Neospora caninum inhibits tumor development by activating the immune response and destroying tumor cells in a B16F10 melanoma model.

Authors:  Xiaojin Li; Meng Qi; Kai He; Haiyan Liu; Wenlan Yan; Lizhuo Zhao; Yanyan Jia; Lei He; Chaochao Lv; Min Zhang; Zhiguo Wei; Wenchao Yan; Tianqi Wang; Fuchang Yu; Weifeng Qian
Journal:  Parasit Vectors       Date:  2022-09-23       Impact factor: 4.047

6.  Antiparasitic Efficacy of Curcumin Against Besnoitia besnoiti Tachyzoites in vitro.

Authors:  María Eugenia Cervantes-Valencia; Carlos Hermosilla; Yazmín Alcalá-Canto; Graciela Tapia; Anja Taubert; Liliana M R Silva
Journal:  Front Vet Sci       Date:  2019-01-11

7.  Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with Schistosoma japonicum Infection.

Authors:  Tina Tuwen Chen; Shihyi Peng; Yanjuan Wang; Yuan Hu; Yujuan Shen; Yuxin Xu; Jianhai Yin; Congshan Liu; Jianping Cao
Journal:  Biomolecules       Date:  2019-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.